גליבק ® 100 מ"ג
novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l
בוסוליף 100 מג
pfizer pharmaceuticals israel ltd - bosutinib as monohydrate - טבליות מצופות פילם - bosutinib as monohydrate 100 mg - bosutinib
בוסוליף 500 מג
pfizer pharmaceuticals israel ltd - bosutinib as monohydrate - טבליות מצופות פילם - bosutinib as monohydrate 500 mg - bosutinib
בספונסה
pfizer pharmaceuticals israel ltd - inotuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - inotuzumab ozogamicin 1 mg/vial - inotuzumab ozogamicin
בוסוליף 400 מג
pfizer pharmaceuticals israel ltd - bosutinib as monohydrate - טבליות מצופות פילם - bosutinib as monohydrate 400 mg - bosutinib
סמבליקס 20 מג
novartis israel ltd - asciminib as hydrochloride - טבליות מצופות פילם - asciminib as hydrochloride 20 mg - asciminib
סמבליקס 40 מג
novartis israel ltd - asciminib as hydrochloride - טבליות מצופות פילם - asciminib as hydrochloride 40 mg - asciminib